A 56-year-old female with pulmonary Mycobacterium avium complex disease started to inhale of liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after discontinuing the treatment, and no recurrence occurred even after resuming intermittent inhalation.